“Towards a strategic research agenda for PPPs on the development of vaccines and immunotherapeutics”
On October 20th, 2016 Flanders Vaccine is happy to host its first edition of “Immunity for Health”: the Flanders Vaccine annual flagship event where all stakeholders, both from the human and animal health sector, working in the field of immunology, vaccinology, immune-oncology and infectious diseases are invited to meet, interact and start collaborations.
This year the event is co-organized with PROVAXS at the occassion of their 10th anniversary and will focus on learning from existing worldwide consortia and on how to implement these best practices in setting up a strategic research agenda for public private partnerships. Moreover, we will offer you the opportunity to pitch new technologies or R&D breakthroughs. In this way, you get to know all stakeholders’ needs, technological specs and possible contributions in order to identify the opportunities you can work on together in 2017. On October 21st, 2016 you can immediately further explore newly made connections via a B-to-B session with one-on-one meetings. Flanders Vaccine also aims to build further on the research topics identified during the Collaboration Workshop in May 2016.
Immunity for Health also focuses on working cross-border to complement international strengths and excellence in research and industry. Flanders Vaccine, in partnership with Flanders Investment & Trade, Visegrad Embassies and FlandersBio is happy to welcome this year a delegation of the immunology-vaccinology-